THERALINK TECHNOLOGIES, INC. — Form D

THERALINK TECHNOLOGIES, INC. of GOLDEN, CO, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-12. The offering totals $4.0M, of which $400K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Andrew KucharchukDirectorGolden, CO
Mick Ruxin, MDDirectorGolden, CO
Thomas Chilcott, IIIExecutive OfficerGolden, CO
Mick Ruxin, MDExecutive OfficerGolden, CO
Danica HolleyDirectorBethesda, MD
Jeffrey BuschDirectorBethesda, MD
Andrew W KucharchukDirectorGolden, CO
Matthew W Schwartz, MDDirectorGolden, CO
Mick RuxinDirectorGolden, CO
Mick RuxinExecutive OfficerGolden, CO
Yvonne ForsDirectorGolden, CO
Thomas W ChilcottExecutive OfficerGolden, CO
ROBERT L ELLIOTTDirectorBATON ROUGE, LA
Brian A Barnett, M.D.Executive OfficerBATON ROUGE, LA
ROBERT N HOLCOMBDirectorBATON ROUGE, LA
DANIEL S HOVERMANDirectorBATON ROUGE, LA
ANDREW A KUCHARCHUKDirectorBATON ROUGE, LA
ANDREW A KUCHARCHUKExecutive OfficerBATON ROUGE, LA
JONATHAN F HEAD, PH.DDirectorBATON ROUGE, LA
CHARLES L RICE, JRDirectorBATON ROUGE, LA
Jonathan F HeadDirectorBaton Rouge, LA
Jonathan F HeadExecutive OfficerBaton Rouge, LA
Charles L Rice, Jr.DirectorBaton Rouge, LA
Andrew F KucharchukExecutive OfficerBaton Rouge, LA
Charles L RiceDirectorBaton Rouge, LA

Other filings by this issuer (7)

FiledFormOfferingSold
2022-12-14D$3.4M—
2019-05-29D$185K$185K
2018-10-09D$1.2M$1.2M
2015-12-30D$11.1M$95K
2015-10-13D$750K$516K
2010-07-09D$175K$175K
2010-06-15D$10K$10K

More